Mediclinic International Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Mediclinic International ha un patrimonio netto totale di £3.7B e un debito totale di £2.0B, che porta il suo rapporto debito/patrimonio netto a 54.1%. Le sue attività totali e le sue passività totali sono rispettivamente £7.9B e £4.2B. L'EBIT di Mediclinic International è £274.0M rendendo il suo rapporto di copertura degli interessi 4.1. Ha liquidità e investimenti a breve termine pari a £454.0M.

Informazioni chiave

54.1%

Rapporto debito/patrimonio netto

UK£1.99b

Debito

Indice di copertura degli interessi	4.1x
Contanti	UK£454.00m
Patrimonio netto	UK£3.67b
Totale passività	UK£4.21b
Totale attività	UK£7.88b

Aggiornamenti recenti sulla salute finanziaria

Here's Why Mediclinic International (LON:MDC) Can Manage Its Debt Responsibly

Jun 28

Recent updates

Here's Why We Think Mediclinic International (LON:MDC) Might Deserve Your Attention Today

Jul 26

Is There An Opportunity With Mediclinic International plc's (LON:MDC) 25% Undervaluation?

Sep 08

Is Mediclinic International (LON:MDC) Using Too Much Debt?

Jun 21

Does This Valuation Of Mediclinic International plc (LON:MDC) Imply Investors Are Overpaying?

May 26

If You Had Bought Mediclinic International's (LON:MDC) Shares Five Years Ago You Would Be Down 63%

Mar 17

What Kind Of Shareholders Hold The Majority In Mediclinic International plc's (LON:MDC) Shares?

Feb 26

Mediclinic International plc (LON:MDC) Could Be Less Than A Year Away From Profitability

Feb 11

Have Mediclinic International plc (LON:MDC) Insiders Been Selling Their Stock?

Jan 27

Estimating The Fair Value Of Mediclinic International plc (LON:MDC)

Jan 18

These 4 Measures Indicate That Mediclinic International (LON:MDC) Is Using Debt Extensively

Jan 01

A Look At Mediclinic International's (LON:MDC) Share Price Returns

Dec 17

Our View On Mediclinic International's (LON:MDC) CEO Pay

Dec 02

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( £1.6B ) di MDC superano le sue passività a breve termine ( £1.0B ).

Passività a lungo termine: Le attività a breve termine di MDC ( £1.6B ) non coprono le sue passività a lungo termine ( £3.2B ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 41.7% ) di MDC è considerato alto.

Riduzione del debito: Il rapporto debito/patrimonio netto di MDC è aumentato da 49.8% a 54.1% negli ultimi 5 anni.

Copertura del debito: Il debito di MDC è ben coperto dal flusso di cassa operativo ( 23.7% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di MDC sono ben coperti dall'EBIT ( 4.1 x copertura).

Mediclinic International Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Financial Conduct Authority Cancels the Listing of Mediclinic Shares on the London Stock Exchange and Delisting of Shares from the JSE and the NSX Expects to Take Effect on 7 June 2023

Mediclinic International's Cancellation of Shares from Official List and Main Market of LSE Expected to Take on 30 May 2023; Delisting of Shares from JSE and NSX Expected to Take Effect from Commencement of Trade on 7 June 2023

Cancellation of Listing of Mediclinic Shares on the LSE Is Expected on 26 May 2023

Mediclinic International plc to Delist

Here's Why Mediclinic International (LON:MDC) Can Manage Its Debt Responsibly

Mediclinic International Ordinary Shares to Be Deleted from OTC Equity

Recent updates

Financial Conduct Authority Cancels the Listing of Mediclinic Shares on the London Stock Exchange and Delisting of Shares from the JSE and the NSX Expects to Take Effect on 7 June 2023

Mediclinic International's Cancellation of Shares from Official List and Main Market of LSE Expected to Take on 30 May 2023; Delisting of Shares from JSE and NSX Expected to Take Effect from Commencement of Trade on 7 June 2023

Mediclinic International plc(LSE:MDC) dropped from FTSE 350 (Ex Investment Companies) Index (GBP)

Cancellation of Listing of Mediclinic Shares on the LSE Is Expected on 26 May 2023

Mediclinic International plc (LSE:MDC) acquired Artisan Biomed.

Mediclinic International plc Approves Final Cash Dividend, Payable on 26 August 2022

Mediclinic International plc to Delist

Mediclinic International plc Approves Final Cash Dividend

Upcoming dividend of UK£0.03 per share

Here's Why We Think Mediclinic International (LON:MDC) Might Deserve Your Attention Today

Estimating The Intrinsic Value Of Mediclinic International plc (LON:MDC)

Here's Why Mediclinic International (LON:MDC) Can Manage Its Debt Responsibly

Remgro Wants Equal Partner in Possible Mediclinic Buyout

Price target increased to UK£4.26

Price target increased to UK£4.09

Mediclinic International Ordinary Shares to Be Deleted from OTC Equity

Independent Non-Executive Director recently bought UK£73k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Mediclinic International plc to Report First Half, 2023 Results on Nov 16, 2022

High number of new directors

Mediclinic International plc to Report Fiscal Year 2022 Results on May 25, 2022

Are Investors Undervaluing Mediclinic International plc (LON:MDC) By 50%?

High number of new directors

Is Mediclinic International (LON:MDC) Using Too Much Debt?

High number of new directors

Mediclinic International (LON:MDC) Takes On Some Risk With Its Use Of Debt

First half 2022 earnings released: EPS UK£0.088 (vs UK£0.02 in 1H 2021)

High number of new directors

High number of new directors

Senior Independent Director J. Grieve has left the company

Independent Non-Executive Director Trevor Petersen has left the company

Is There An Opportunity With Mediclinic International plc's (LON:MDC) 25% Undervaluation?

Full year 2021 earnings released: EPS UK£0.092 (vs UK£0.43 loss in FY 2020)

Is Mediclinic International (LON:MDC) Using Too Much Debt?

Consensus forecasts updated

Mediclinic International plc Provides Revenue Guidance for Fiscal 2022

Full year 2021 earnings released: EPS UK£0.092 (vs UK£0.43 loss in FY 2020)

Does This Valuation Of Mediclinic International plc (LON:MDC) Imply Investors Are Overpaying?

If You Had Bought Mediclinic International's (LON:MDC) Shares Five Years Ago You Would Be Down 63%

New 90-day high: UK£3.06

What Kind Of Shareholders Hold The Majority In Mediclinic International plc's (LON:MDC) Shares?

Mediclinic International plc (LON:MDC) Could Be Less Than A Year Away From Profitability

Non-Executive Director recently sold UK£52k worth of stock

Have Mediclinic International plc (LON:MDC) Insiders Been Selling Their Stock?

Estimating The Fair Value Of Mediclinic International plc (LON:MDC)

These 4 Measures Indicate That Mediclinic International (LON:MDC) Is Using Debt Extensively

A Look At Mediclinic International's (LON:MDC) Share Price Returns

Our View On Mediclinic International's (LON:MDC) CEO Pay

First half 2021 earnings released: EPS UK£0.02

Revenue beats expectations, earnings disappoint

New 90-day high: UK£3.19

New 90-day high: UK£2.95

New 90-day low - UK£2.46

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane